Table 3.

Multivariate analysis.

Outcomes	N	HR (95% CI)	P value
Overall survival
Main effect
Chemotherapy	261	Reference
Allogeneic HCT	217	2.00 (1.50–2.66)	<0.001
Body mass index (kg/m2)
<30	332	Reference
≥30	146	2.17 (1.63–2.89)	<0.001
Disease-free survival
Main effect
Chemotherapy	261	Reference
Allogeneic HCT	215	1.62 (1.25–2.12)	<0.001
Body mass index (kg/m2)
<30	331	Reference
≥30	145	1.97 (1.51–2.57)	<0.001
Relapse
Allogeneic HCT vs. chemotherapy ≤ 15 months after CR1		1.78 (1.10–2.88)	0.02
Allogeneic HCT vs. chemotherapy > 15 months after CR1		0.34 (0.19–0.62)	<0.001
Body mass index (kg/m2)
<30	331	Reference
≥30	145	1.84 (1.31–2.59)	<0.001
Non-relapse mortality
Main effect
Chemotherapy	261	Reference
Allogeneic HCT	215	5.41 (3.23–9.06)	<0.001
Body mass index (kg/m2)
<30	331	Reference
≥30	145	2.10 (1.37–3.23)	<0.001